Rajeev Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rajeev Kumar has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Anil K Pandey
1 shared publicationAnil K. Pandey
Department of Nuclear Medicine and PET Cyclotron Facility, All India Institute of Medical Sciences, New Delhi
1 shared publicationChandra S. Bal
Department of Nuclear Medicine and PET Cyclotron Facility, All India Institute of Medical Sciences, New Delhi
1 shared publicationChandrasekhar Bal
1 shared publicationGurupad Bandopadhayaya
1 shared publicationKamal Deep
Health Physics Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India
1 shared publication
Latest Publications
- Open Access
- 1 July 2024
- Published by Scientific Scholar in Indian Journal of Nuclear Medicine
- Vol. 39 (4) , 243-250
Mandatory Requirements for Planning and Commissioning of Medical Cyclotron Facility
Over the last 15 years, there has been substantial growth in the installation of medical cyclotrons. This is mainly due to the increased demand for the production of positron emission tomography radiopharmaceuticals. In every country, there is a regulatory body that regulates the uses of medical cyclotron intending to protect occupational workers, the public, and the environment. It regulates the entire stages of such facilities, which mainly controls regulatory activities such as construction, commissioning, operation, and decommissioning. This article primarily highlights the key practices for planning and installation of a medical cyclotron facility (MCF). It also covers the particular aspects that should be considered in the early stages of project planning and provides information for best practices and challenges. If these aspects are properly addressed, then it ensures the safe operation of the MCF. The texts also elaborate on the necessary requirements for effective planning of the MCF, such as layout and space considerations, workload plan and maximum research capacity of the institute and equipment, shielding requirements, water cooling circuit, storage of radioactive components, management of radioactive waste from medical cyclotron and radiochemistry laboratory, construction and commissioning project management, exhaust system and filtration options, plans for staffing and training, and combination of equipment safety systems and building safety systems.
- 1 July 2024
- Published by Scientific Scholar in Indian Journal of Nuclear Medicine
- Vol. 39 (4) , 243-250
Open AccessMandatory Requirements for Planning and Commissioning of Medical Cyclotron Facility
Over the last 15 years, there has been substantial growth in the installation of medical cyclotrons. This is mainly due to the increased demand for the production of positron emission tomography radiopharmaceuticals. In every country, there is a regulatory body that regulates the uses of medical cyclotron intending to protect occupational workers, the public, and the environment. It regulates the entire stages of such facilities, which mainly controls regulatory activities such as construction, commissioning, operation, and decommissioning. This article primarily highlights the key practices for planning and installation of a medical cyclotron facility (MCF). It also covers the particular aspects that should be considered in the early stages of project planning and provides information for best practices and challenges. If these aspects are properly addressed, then it ensures the safe operation of the MCF. The texts also elaborate on the necessary requirements for effective planning of the MCF, such as layout and space considerations, workload plan and maximum research capacity of the institute and equipment, shielding requirements, water cooling circuit, storage of radioactive components, management of radioactive waste from medical cyclotron and radiochemistry laboratory, construction and commissioning project management, exhaust system and filtration options, plans for staffing and training, and combination of equipment safety systems and building safety systems.
- 1 January 2017
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 38 (1) , 10-14
Practical experience and challenges in the operation of medical cyclotron
Objective The aim of this article was to share 10 years of operational experience of medical cyclotron and to provide working knowledge on the same. This experience has helped us gain working knowledge on cyclotron operation with practical points, which may help in improving 18F yield, minimizing the breakdown time, and help in the prevention of the occurrence of unusual events. Materials and methods Our facility has a self-shielded radioisotope delivery system eclipse 111 medical cyclotron with an 11 MeV proton beam in use for the past 10 years to produce positron emitters – namely, 18F, 13N, and 18F-2 gas – for PET imaging. During 18F production, we have followed a set protocol comprising the following: monitoring target pressure, rinsing the target with 16O water just immediately after bombardment, ion source feedback, radiofrequency (RF) feedback, and recording any unusual events that occurred during the operation. Besides this, enrichment of 18O water, target volume, target current, energy of the beam, variation in argon pressure on the target, bombardment duration, target status (new or old target or total number of previous bombardments on the same target), status of the delivery lines from target to the radiochemistry module (old or new) were also recorded. Results Rinsing with 16O water immediately after bombardment increases the life of the target and delivery line. The frequent problems encountered were with the ion source, RF, and target foil rupture. These problems were solved by rebuilding the ion source, changing the fuse of RF, and rebuilding the target. Conclusion 18F yield can be increased by rinsing with 16O water immediately after bombardment. The effect of target leak – that is, rupture of vacuum window – can be avoided by immediate stoppage of bombardment.
- 1 January 2017
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 38 (1) , 10-14
Practical experience and challenges in the operation of medical cyclotron
Objective The aim of this article was to share 10 years of operational experience of medical cyclotron and to provide working knowledge on the same. This experience has helped us gain working knowledge on cyclotron operation with practical points, which may help in improving 18F yield, minimizing the breakdown time, and help in the prevention of the occurrence of unusual events. Materials and methods Our facility has a self-shielded radioisotope delivery system eclipse 111 medical cyclotron with an 11 MeV proton beam in use for the past 10 years to produce positron emitters – namely, 18F, 13N, and 18F-2 gas – for PET imaging. During 18F production, we have followed a set protocol comprising the following: monitoring target pressure, rinsing the target with 16O water just immediately after bombardment, ion source feedback, radiofrequency (RF) feedback, and recording any unusual events that occurred during the operation. Besides this, enrichment of 18O water, target volume, target current, energy of the beam, variation in argon pressure on the target, bombardment duration, target status (new or old target or total number of previous bombardments on the same target), status of the delivery lines from target to the radiochemistry module (old or new) were also recorded. Results Rinsing with 16O water immediately after bombardment increases the life of the target and delivery line. The frequent problems encountered were with the ion source, RF, and target foil rupture. These problems were solved by rebuilding the ion source, changing the fuse of RF, and rebuilding the target. Conclusion 18F yield can be increased by rinsing with 16O water immediately after bombardment. The effect of target leak – that is, rupture of vacuum window – can be avoided by immediate stoppage of bombardment.
- 7 August 2014
- Vol. 17 (2) , 106-10
Production of the PET bone agent (18)F-fluoride ion, simultaneously with (18)F-FDG by a single run of the medical cyclotron with minimal radiation exposure- a novel technique.
Our aim was to establish an easy and convenient procedure for the preparation of fluorine-18-sodium fluoride ((18)F-NaF) for bone positron emission tomography (PET) during routine (18)F-FDG production using the Explora FDG4 radiochemistry module (EFRM) by single run of Cyclotron with negligible radiation exposure. We compared three techniques for (18)F-NaF production during routine PET radiochemistry at our setup. In one method we used synthesis module and in other two methods we did not. In the first and third method, F-18 was directly extracted from the V-vial and in the second method, (18)F-NaF was extracted by post processing from the EFRM. In the first method, F-18 was extracted directly from V-vial manually by opening the V-vial cap. In the second method, Explora FDG-4 Module was used. First, F-18 was transferred from the V-vial. Then, after post processing in EFRM, pure F-18 was obtained in the product vial. In the third method, pure F-18 was obtained in the product vial with the help of a mechanical robotic arm. The above were followed by routine quality control of (18)F-NaF produced by each method. Results of quality control of the (18)F-NaF obtained by all three methods satisfied all parameters prescribed by the United States Pharmacopeia (USP) and the British Pharmacopeia (BP) including biological, physical and chemical specifications. The radiochemical purity was 98.5±1.5% with Rf 0.006. The level of Kryptofix-222 (K222) in (18)F-NaF was within the prescribed limit. Mean pH of (18)F-NaF was 6.0±1.5. The exposure rate around the hot cell was negligible. In conclusion, from the results it was obvious that by our method number three (18)F-NaF was directly obtained from the V-vial using mechanical robotic arms. This method was the most appropriate with minimized radiation exposure to the handling Radiochemist and was also saving time as compared to the other two methods.
- 7 August 2014
- Vol. 17 (2) , 106-10
Production of the PET bone agent (18)F-fluoride ion, simultaneously with (18)F-FDG by a single run of the medical cyclotron with minimal radiation exposure- a novel technique.
Our aim was to establish an easy and convenient procedure for the preparation of fluorine-18-sodium fluoride ((18)F-NaF) for bone positron emission tomography (PET) during routine (18)F-FDG production using the Explora FDG4 radiochemistry module (EFRM) by single run of Cyclotron with negligible radiation exposure. We compared three techniques for (18)F-NaF production during routine PET radiochemistry at our setup. In one method we used synthesis module and in other two methods we did not. In the first and third method, F-18 was directly extracted from the V-vial and in the second method, (18)F-NaF was extracted by post processing from the EFRM. In the first method, F-18 was extracted directly from V-vial manually by opening the V-vial cap. In the second method, Explora FDG-4 Module was used. First, F-18 was transferred from the V-vial. Then, after post processing in EFRM, pure F-18 was obtained in the product vial. In the third method, pure F-18 was obtained in the product vial with the help of a mechanical robotic arm. The above were followed by routine quality control of (18)F-NaF produced by each method. Results of quality control of the (18)F-NaF obtained by all three methods satisfied all parameters prescribed by the United States Pharmacopeia (USP) and the British Pharmacopeia (BP) including biological, physical and chemical specifications. The radiochemical purity was 98.5±1.5% with Rf 0.006. The level of Kryptofix-222 (K222) in (18)F-NaF was within the prescribed limit. Mean pH of (18)F-NaF was 6.0±1.5. The exposure rate around the hot cell was negligible. In conclusion, from the results it was obvious that by our method number three (18)F-NaF was directly obtained from the V-vial using mechanical robotic arms. This method was the most appropriate with minimized radiation exposure to the handling Radiochemist and was also saving time as compared to the other two methods.